Nanalysis Historical Balance Sheet

NSCI Stock

CAD 0.33 0.01 2.94%

Trend analysis of Nanalysis Scientific Corp balance sheet accounts such as Total Stockholder Equity of 17.8 M provides information on Nanalysis Scientific's total assets, liabilities, and equity, which is the actual value of Nanalysis Scientific Corp to its prevalent stockholders. By breaking down trends over time using Nanalysis Scientific balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Nanalysis Scientific Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nanalysis Scientific Corp is a good buy for the upcoming year.

Nanalysis Scientific Inventory

3.16 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanalysis Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About Nanalysis Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Nanalysis Scientific Corp at a specified time, usually calculated after every quarter, six months, or one year. Nanalysis Scientific Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nanalysis Scientific and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nanalysis currently owns. An asset can also be divided into two categories, current and non-current.

Nanalysis Scientific Balance Sheet Chart

At this time, Nanalysis Scientific's Other Liabilities is fairly stable compared to the past year. Non Current Liabilities Total is likely to climb to about 16.5 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 406.6 K in 2024.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Total Assets

Total assets refers to the total amount of Nanalysis Scientific assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nanalysis Scientific Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Nanalysis Scientific balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Nanalysis Scientific Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Nanalysis Scientific's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Nanalysis Scientific Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanalysis Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	2.0M	810K	428K	406.6K
Total Assets	37.8M	69.9M	53.8M	31.5M

Other Current Liab Total Assets

Nanalysis Scientific balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Other Liab	Net Debt	Non Current Assets Total	Common Stock Shares Outstanding	Non Current Liabilities Total
Total Assets		0.32	0.89	0.98	0.88	-0.75	0.97	0.41	0.86	0.62	0.88	0.98	-0.17	0.84	0.86	0.73	0.95	-0.7	0.98	0.88	0.92	0.89	0.61	0.98	0.93	0.77
Other Current Liab	0.32		0.2	0.42	0.38	-0.01	0.4	0.66	0.52	-0.01	0.11	0.3	-0.51	0.14	0.52	-0.08	0.45	-0.54	0.47	0.38	0.53	0.35	0.03	0.19	0.12	0.05
Total Current Liabilities	0.89	0.2		0.84	0.93	-0.95	0.9	0.22	0.93	0.89	0.85	0.89	-0.15	0.99	0.92	0.94	0.85	-0.56	0.85	0.95	0.81	0.97	0.86	0.91	0.96	0.96
Total Stockholder Equity	0.98	0.42	0.84		0.91	-0.68	0.93	0.58	0.88	0.56	0.84	0.92	-0.24	0.78	0.88	0.65	0.98	-0.77	0.98	0.9	0.94	0.88	0.57	0.92	0.86	0.71
Net Tangible Assets	0.88	0.38	0.93	0.91		-0.85	0.86	0.5	0.97	0.8	0.85	0.81	-0.33	0.91	0.97	0.83	0.92	-0.75	0.87	1.0	0.91	0.97	0.83	0.83	0.88	0.89
Retained Earnings	-0.75	-0.01	-0.95	-0.68	-0.85		-0.75	-0.01	-0.84	-0.98	-0.8	-0.75	0.16	-0.98	-0.83	-0.99	-0.68	0.46	-0.67	-0.87	-0.69	-0.89	-0.96	-0.8	-0.91	-1.0
Accounts Payable	0.97	0.4	0.9	0.93	0.86	-0.75		0.42	0.88	0.64	0.87	0.97	-0.08	0.84	0.88	0.73	0.95	-0.65	0.94	0.88	0.92	0.91	0.61	0.94	0.93	0.77
Cash	0.41	0.66	0.22	0.58	0.5	-0.01	0.42		0.45	-0.04	0.29	0.3	-0.37	0.15	0.45	0.0	0.65	-0.57	0.49	0.47	0.59	0.42	0.04	0.23	0.2	0.08
Other Assets	0.86	0.52	0.93	0.88	0.97	-0.84	0.88	0.45		0.8	0.78	0.83	-0.39	0.91	1.0	0.79	0.89	-0.74	0.88	0.98	0.91	0.97	0.81	0.82	0.85	0.87
Long Term Debt	0.62	-0.01	0.89	0.56	0.8	-0.98	0.64	-0.04	0.8		0.73	0.62	-0.19	0.94	0.79	0.96	0.58	-0.4	0.55	0.83	0.61	0.84	0.99	0.67	0.82	0.98
Net Receivables	0.88	0.11	0.85	0.84	0.85	-0.8	0.87	0.29	0.78	0.73		0.84	0.07	0.83	0.78	0.8	0.86	-0.67	0.8	0.84	0.87	0.84	0.72	0.85	0.93	0.81
Inventory	0.98	0.3	0.89	0.92	0.81	-0.75	0.97	0.3	0.83	0.62	0.84		-0.12	0.83	0.83	0.73	0.9	-0.62	0.95	0.83	0.87	0.87	0.59	0.98	0.94	0.76
Other Stockholder Equity	-0.17	-0.51	-0.15	-0.24	-0.33	0.16	-0.08	-0.37	-0.39	-0.19	0.07	-0.12		-0.17	-0.39	-0.04	-0.21	0.38	-0.26	-0.32	-0.33	-0.23	-0.29	-0.13	-0.07	-0.17
Total Liab	0.84	0.14	0.99	0.78	0.91	-0.98	0.84	0.15	0.91	0.94	0.83	0.83	-0.17		0.91	0.97	0.79	-0.53	0.78	0.94	0.77	0.96	0.92	0.86	0.94	0.99
Deferred Long Term Liab	0.86	0.52	0.92	0.88	0.97	-0.83	0.88	0.45	1.0	0.79	0.78	0.83	-0.39	0.91		0.79	0.89	-0.74	0.88	0.98	0.91	0.96	0.81	0.82	0.85	0.87
Short Long Term Debt	0.73	-0.08	0.94	0.65	0.83	-0.99	0.73	0.0	0.79	0.96	0.8	0.73	-0.04	0.97	0.79		0.67	-0.38	0.64	0.85	0.64	0.88	0.94	0.78	0.9	0.99
Total Current Assets	0.95	0.45	0.85	0.98	0.92	-0.68	0.95	0.65	0.89	0.58	0.86	0.9	-0.21	0.79	0.89	0.67		-0.75	0.94	0.92	0.95	0.91	0.6	0.87	0.86	0.72
Short Term Debt	-0.7	-0.54	-0.56	-0.77	-0.75	0.46	-0.65	-0.57	-0.74	-0.4	-0.67	-0.62	0.38	-0.53	-0.74	-0.38	-0.75		-0.77	-0.72	-0.85	-0.65	-0.46	-0.6	-0.58	-0.49
Intangible Assets	0.98	0.47	0.85	0.98	0.87	-0.67	0.94	0.49	0.88	0.55	0.8	0.95	-0.26	0.78	0.88	0.64	0.94	-0.77		0.87	0.92	0.87	0.55	0.94	0.86	0.7
Common Stock	0.88	0.38	0.95	0.9	1.0	-0.87	0.88	0.47	0.98	0.83	0.84	0.83	-0.32	0.94	0.98	0.85	0.92	-0.72	0.87		0.9	0.99	0.85	0.84	0.9	0.91
Property Plant Equipment	0.92	0.53	0.81	0.94	0.91	-0.69	0.92	0.59	0.91	0.61	0.87	0.87	-0.33	0.77	0.91	0.64	0.95	-0.85	0.92	0.9		0.88	0.64	0.84	0.85	0.72
Other Liab	0.89	0.35	0.97	0.88	0.97	-0.89	0.91	0.42	0.97	0.84	0.84	0.87	-0.23	0.96	0.96	0.88	0.91	-0.65	0.87	0.99	0.88		0.83	0.86	0.92	0.92
Net Debt	0.61	0.03	0.86	0.57	0.83	-0.96	0.61	0.04	0.81	0.99	0.72	0.59	-0.29	0.92	0.81	0.94	0.6	-0.46	0.55	0.85	0.64	0.83		0.64	0.8	0.96
Non Current Assets Total	0.98	0.19	0.91	0.92	0.83	-0.8	0.94	0.23	0.82	0.67	0.85	0.98	-0.13	0.86	0.82	0.78	0.87	-0.6	0.94	0.84	0.84	0.86	0.64		0.95	0.8
Common Stock Shares Outstanding	0.93	0.12	0.96	0.86	0.88	-0.91	0.93	0.2	0.85	0.82	0.93	0.94	-0.07	0.94	0.85	0.9	0.86	-0.58	0.86	0.9	0.85	0.92	0.8	0.95		0.91
Non Current Liabilities Total	0.77	0.05	0.96	0.71	0.89	-1.0	0.77	0.08	0.87	0.98	0.81	0.76	-0.17	0.99	0.87	0.99	0.72	-0.49	0.7	0.91	0.72	0.92	0.96	0.8	0.91

Click cells to compare fundamentals

Nanalysis Scientific Account Relationship Matchups

Nanalysis Scientific balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	18.3M	24.0M	37.8M	69.9M	53.8M	31.5M
Other Current Liab	705K	2.6M	2.0M	810K	428K	406.6K
Total Current Liabilities	1.6M	5.6M	8.6M	13.5M	14.6M	15.3M
Total Stockholder Equity	15.1M	14.3M	24.0M	35.1M	23.5M	17.8M
Net Tangible Assets	7.9M	14.5M	13.8M	22.0M	25.2M	26.5M
Retained Earnings	(4.2M)	(7.9M)	(9.7M)	(18.8M)	(35.0M)	(33.2M)
Accounts Payable	678K	2.6M	4.4M	5.8M	5.1M	3.0M
Cash	6.6M	3.2M	10.4M	3.5M	759K	721.1K
Other Assets	3.8M	5.9M	12.1M	12.5M	14.4M	15.1M
Long Term Debt	1.0M	2.8M	2.7M	3.8M	12.6M	13.2M
Net Receivables	2.6M	1.8M	5.0M	6.1M	8.3M	4.4M
Inventory	857K	2.8M	3.7M	7.4M	5.8M	3.2M
Other Stockholder Equity	817.7K	997.1K	215K	714K	642.6K	553.5K
Total Liab	3.2M	9.6M	13.8M	22.3M	30.3M	31.9M
Deferred Long Term Liab	3.8M	5.9M	12.1M	12.5M	14.4M	15.1M
Short Long Term Debt	116K	209K	1.9M	3.7M	6.5M	6.8M
Total Current Assets	10.2M	9.4M	20.8M	22.0M	17.9M	12.8M
Intangible Assets	6.5M	12.7M	14.1M	26.6M	15.9M	11.1M
Common Stock	10.0M	18.3M	20.7M	31.3M	36.0M	37.8M
Property Plant Equipment	1.1M	1.6M	2.0M	2.5M	2.9M	1.6M
Non Current Assets Total	8.1M	14.6M	17.0M	47.9M	35.9M	23.7M
Common Stock Shares Outstanding	62.4M	66.0M	77.2M	94.4M	101.9M	85.0M
Non Current Liabilities Total	1.6M	3.3M	5.2M	8.8M	15.7M	16.5M
Capital Lease Obligations	371K	752K	1.3M	3.3M	2.9M	1.6M
Net Invested Capital	16.3M	17.4M	28.6M	42.6M	42.5M	28.7M
Capital Stock	18.3M	20.7M	31.3M	49.0M	53.2M	33.4M
Net Working Capital	8.5M	3.0M	12.1M	8.4M	3.3M	3.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Nanalysis Stock Analysis

When running Nanalysis Scientific's price analysis, check to measure Nanalysis Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanalysis Scientific is operating at the current time. Most of Nanalysis Scientific's value examination focuses on studying past and present price action to predict the probability of Nanalysis Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanalysis Scientific's price. Additionally, you may evaluate how the addition of Nanalysis Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC